ClinicalTrials.Veeva

Menu

Microneedling Alone vs Microneedling With PRP in the Treatment of Macular Amyloidosis; a Split Face Comparative Study

Cairo University (CU) logo

Cairo University (CU)

Status

Not yet enrolling

Conditions

Macular Amyloidosis

Treatments

Device: microneedling with PRP
Device: microneedling

Study type

Interventional

Funder types

Other

Identifiers

NCT07360860
MS-59-2025

Details and patient eligibility

About

This study is going to asses and compare the efficacy of treatment of macular amyloidosis using microneedling vs PRP with microneedling. Pruritus and pigmentation will be assessed.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: • Both genders were included.

  • Patients above 18 years old.
  • Patients diagnosed by macular amyloidosis, proved by dermoscopy and histopathology.

Exclusion Criteria: • Prior use of topical therapies in the previous 4 weeks.

  • Prior use of any procedures such as chemical peel or laser treatment in the previous 1 month.
  • Prior use of any systemic treatment for macular amyloidosis in the past 12 weeks.
  • Patients with other skin conditions (e.g., psoriasis, eczema).
  • Immunocompromised patients (HIV, chemotherapy).
  • Patients with history of any type of autoimmune disorders, coagulopathies, and keloid tendency.
  • Known or suspected allergy to ingredients

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

microneedling
Active Comparator group
Description:
microneedling will be done on the first arm
Treatment:
Device: microneedling
macular amyloidosis treated with microneedling and PRP
Active Comparator group
Treatment:
Device: microneedling with PRP

Trial contacts and locations

0

Loading...

Central trial contact

Amira Elbendary, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems